CapsoVision (NASDAQ:CV) Stock Rating Upgraded by Zacks Research

CapsoVision (NASDAQ:CV) was upgraded by research analysts at Zacks Research to a “hold” rating in a note issued to investors on Monday, Zacks reports.

Several other equities analysts have also recently issued reports on the company. Benchmark reaffirmed a “speculative buy” rating on shares of CapsoVision in a research report on Friday, August 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of CapsoVision in a report on Monday, June 29th. Finally, Roth Capital began coverage on CapsoVision in a research report on Friday, August 28th. They set a “buy” rating and a $9.00 price objective on the stock. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $9.50.

CapsoVision Stock Performance

NASDAQ:CV opened at $5.87 on Monday. The firm has a market cap of $293.78 million, a P/E ratio of -12.49 and a beta of -2.47. CapsoVision has a fifty-two week low of $3.43 and a fifty-two week high of $15.37. The firm has a 50-day simple moving average of $6.55 and a two-hundred day simple moving average of $6.42.

CapsoVision (NASDAQ:CV) last issued its earnings results on Thursday, August 13th. The company reported ($0.15) earnings per share (EPS) for the quarter. CapsoVision had a negative return on equity of 177.85% and a negative net margin of 214.74%.The firm had revenue of $3.64 million during the quarter. On average, equities research analysts predict that CapsoVision will post -0.56 EPS for the current year.

Insider Buying and Selling at CapsoVision

In other CapsoVision news, major shareholder Eliyahou Et Al Harari acquired 81,300 shares of the stock in a transaction dated Wednesday, July 8th. The shares were acquired at an average cost of $6.09 per share, for a total transaction of $495,117.00. Following the completion of the transaction, the insider directly owned 3,282,051 shares of the company’s stock, valued at approximately $19,987,690.59. The trade was a 2.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last 90 days, insiders have acquired 156,218 shares of company stock worth $1,007,902. 2.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in CapsoVision during the 2nd quarter valued at approximately $14,372,000. Bank of New York Mellon Corp purchased a new stake in shares of CapsoVision during the 2nd quarter worth approximately $569,000. State Street Corp raised its holdings in shares of CapsoVision by 340.7% during the 4th quarter. State Street Corp now owns 85,929 shares of the company’s stock worth $919,000 after acquiring an additional 66,429 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of CapsoVision by 34.1% during the 4th quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock valued at $1,649,000 after acquiring an additional 39,231 shares during the last quarter. Finally, Deutsche Bank AG bought a new position in shares of CapsoVision during the 2nd quarter valued at approximately $263,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.